Recursion Pharmaceuticals Inc (NASDAQ:RXRX)’s traded shares stood at 32.88 million during the last session, with the company’s beta value hitting 0.87. At the close of
In the last trading session, 59.74 million Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares changed hands as the company’s beta touched 0.83. With the company’s per share
During the last session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX)’s traded shares were 21.49 million, with the beta value of the company hitting 0.86. At the end
In today’s recent session, 7.24 million shares of the Recursion Pharmaceuticals Inc (NASDAQ:RXRX) have been traded, and its beta is 0.89. Most recently the company’s
Recursion Pharmaceuticals Inc (NASDAQ:RXRX)’s traded shares stood at 16.52 million during the last session, with the company’s beta value hitting 0.86. At the close of
In the last trading session, 14.01 million Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares changed hands as the company’s beta touched 0.85. With the company’s per share
In last trading session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) saw 22.15 million shares changing hands with its beta currently measuring 0.87. Company’s recent per share price
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) has a beta value of 0.96 and has seen 14.66 million shares traded in the last trading session. The company, currently
In the last trading session, 31.36 million shares of the Recursion Pharmaceuticals Inc (NASDAQ:RXRX) were traded, and its beta was 0.97. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne